|

Liver Disease Clinical Trials in Michigan

54 recruiting studies across 23 cities

All Trials in Michigan

Phase
Trial Phase Location
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisPhase 3Ann Arbor
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaPhase 2Ann Arbor
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaPhase 1/2Ann Arbor
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaPhase 1Ann Arbor
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHPhase 3Ann Arbor
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver DiseaseN/AAnn Arbor
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver CancerPhase 2Ann Arbor
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver NodulesN/AAnn Arbor
DILIN - Prospective Study—Ann Arbor
Drug-Induced Liver Injury (DILI) Network Retrospective—Ann Arbor
Functional Assessment in Liver Transplantation—Ann Arbor
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesPhase 2Ann Arbor
National Liver Cancer Screening TrialPhase 4Ann Arbor
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/AAnn Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—Ann Arbor
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver MetastasesPhase 2Ann Arbor
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin ProteinPhase 3Ann Arbor
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)Phase 3Ann Arbor
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)Phase 3Ann Arbor
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2Ann Arbor
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialPhase 3Ann Arbor
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 2Ann Arbor
Thermoacoustic Method for Estimating Liver Fat Fraction—Ann Arbor
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.Phase 3Ann Arbor
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialPhase 3Brownstown
The Vanguard Study: Testing a New Way to Screen for CancerN/ABrownstown
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)Phase 3Chesterfield
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Phase 3Clinton Township
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHPhase 3Clinton Township
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisPhase 3Clinton Township
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisPhase 3Clinton Township
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsPhase 1/2Dearborn
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsPhase 1/2Detroit
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).Phase 2Detroit
A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsPhase 1Detroit
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)Phase 2Detroit
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Phase 1/2Detroit
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver DiseasePhase 2Detroit
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation—Detroit
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver DiseaseN/ADetroit
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) PatientsN/ADetroit
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 3Detroit
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT—Detroit
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)—Detroit
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsPhase 1Detroit
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/2Detroit
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated CirrhosisPhase 3Detroit
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsPhase 1Detroit
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsPhase 1Grand Rapids
A Study of MGC026 in Participants With Advanced Solid TumorsPhase 1Grand Rapids
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 1Grand Rapids
SMART Diets for MASLDPhase 2Grand Rapids
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Phase 1Grand Rapids
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver DiseaseN/ALansing

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.